We've found
4,191
archived clinical trials in
Constipation
We've found
4,191
archived clinical trials in
Constipation
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Dose-ranging Study to Assess Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC)
Updated: 10/3/2017
A Randomized, 4-Week, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of SP-333 for the Treatment of Opioid-induced Constipation (OIC) in Patients With Non-malignant Chronic Pain Receiving Opioid Therapy
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C)
Updated: 10/3/2017
A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling
Updated: 10/3/2017
Click here to add this to my saved trials